EUVIMEDEUVIMED entdecken
Crossref

Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy

Zaigang Zhou, Cheng Li, Jiahao Liu, Wei Xiong, Huan Ding, Sheng Wu, Zhengxiang Wang, Zhipeng Li, Long Wang, Jianliang Shen

Cell Biomaterials · 2026-08 · 100551

DOI: 10.1016/j.celbio.2026.100551 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biomaterials, 2026-08. Verfasst von Zaigang Zhou und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • National Key Research and Development Program of China
  • Wenzhou Medical University
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Zhou, Z., Li, C., Liu, J., Xiong, W., Ding, H., Wu, S., Wang, Z., Li, Z., Wang, L., & Shen, J. (2026). Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy. Cell Biomaterials, 100551. https://doi.org/10.1016/j.celbio.2026.100551

Vancouver

Zhou Z, Li C, Liu J, Xiong W, Ding H, Wu S, et al. Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy. Cell Biomaterials. 2026:100551. doi:10.1016/j.celbio.2026.100551

BibTeX
@article{Zhou2026,
  author = {Zhou, Zaigang and Li, Cheng and Liu, Jiahao and Xiong, Wei and Ding, Huan and Wu, Sheng and Wang, Zhengxiang and Li, Zhipeng and Wang, Long and Shen, Jianliang},
  title = {Nanoparticle-mediated tumor mitochondria-selective iron disruption facilitates cancer immunotherapy},
  journal = {Cell Biomaterials},
  year = {2026},
  pages = {100551},
  doi = {10.1016/j.celbio.2026.100551}
}
Kostenlos starten →